CID 380631

3,4-dihydro-2h-[1,3]thiazino[3,2-a]benzimidazol-3-ol

Structural Information

Molecular Formula
C10H10N2OS
SMILES
C1C(CSC2=NC3=CC=CC=C3N21)O
InChI
InChI=1S/C10H10N2OS/c13-7-5-12-9-4-2-1-3-8(9)11-10(12)14-6-7/h1-4,7,13H,5-6H2
InChIKey
BLOJMWLHCBDQHM-UHFFFAOYSA-N
Compound name
3,4-dihydro-2H-[1,3]thiazino[3,2-a]benzimidazol-3-ol
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

10
References

5
Patents

206.05139 Da
Monoisotopic Mass

1.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 207.05867 139.4
[M+Na]+ 229.04061 150.4
[M-H]- 205.04411 141.6
[M+NH4]+ 224.08521 160.2
[M+K]+ 245.01455 145.9
[M+H-H2O]+ 189.04865 133.6
[M+HCOO]- 251.04959 154.2
[M+CH3COO]- 265.06524 152.5
[M+Na-2H]- 227.02606 145.0
[M]+ 206.05084 140.9
[M]- 206.05194 140.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.